Nanoscale CaO2 materials for synergistic transarterial chemoembolization in a VX2 orthotopic rabbit liver cancer model
- PMID: 36241014
- DOI: 10.1016/j.actbio.2022.09.074
Nanoscale CaO2 materials for synergistic transarterial chemoembolization in a VX2 orthotopic rabbit liver cancer model
Abstract
Transcatheter arterial chemoembolization (TACE) is extensively used in the treatment of hepatocellular carcinoma (HCC), but its efficacy is usually limited to secondary tumor hypoxia and other progressive exacerbation of the abnormal tumor microenvironment (TME). Herein, we synthesized polyvinyl pyrrolidone (PVP)-coated CaO2 nanoparticles (CaO2 NPs) and applied them as a synergistic agent to improve the antitumor efficacy of TACE. After injection into the tumor, CaO2 NPs reacted with water to generate abundant oxygen, hydroxyl ions (OH-), and calcium ions (Ca2+), thereby relieving tumor hypoxia, neutralizing acid, and overloading Ca2+ to mediate antitumor effects. Moreover, the effect of chemotherapeutic drugs within the TACE was improved due to the modulated TME. CaO2 NPs efficiently regulated the TME and improved the antitumor effect of doxorubicin under hypoxia conditions in vitro. Compared to other groups, the TACE+CaO2 NPs group achieved the lowest tumor growth rate, highest tumor necrosis rate, lowest expression of histological markers associated with hypoxia and angiogenesis (HIF-α, VEGF, and CD31), and highest CD8+ T cell recruitment in vivo. Thus, these findings demonstrated that CaO2 NPs provide synergy for TACE therapy in the VX2 orthotopic rabbit liver cancer model, suggesting that they have a potential broad clinical application. STATEMENT OF SIGNIFICANCE: The efficacy of transcatheter arterial chemoembolization (TACE) for treatment of hepatocellular carcinoma is usually limited to secondary tumor hypoxia and other progressive exacerbation of the abnormal tumor microenvironment (TME). To address this issue, we synthesized CaO2 nanoparticles (CaO2 NPS) which would react with water to generate abundant oxygen, hydroxyl ions (OH-), and calcium ions (Ca2+), thereby relieving tumor hypoxia, neutralizing the acidic TME, and inducing Ca2+ overloading. The efficacy of CaO2 NPs in combination with TACE was investigated in an orthotopic rabbit liver cancer model, and the results showed the great synergetic antitumor effect of TACE and CaO2 NPs.
Keywords: Calcium peroxide; Hepatocellular carcinoma; Transcatheter arterial chemoembolization; Tumor microenvironment; VX2 tumor.
Copyright © 2022 The Authors. Published by Elsevier Ltd.. All rights reserved.
Conflict of interest statement
Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Similar articles
-
Gelation embolism agents suppress clinical TACE-incited pro-metastatic microenvironment against hepatocellular carcinoma progression.EBioMedicine. 2024 Nov;109:105436. doi: 10.1016/j.ebiom.2024.105436. Epub 2024 Oct 30. EBioMedicine. 2024. PMID: 39476535 Free PMC article.
-
Autophagy-Targeted Calcium Phosphate Nanoparticles Enable Transarterial Chemoembolization for Enhanced Cancer Therapy.ACS Appl Mater Interfaces. 2023 Mar 8;15(9):11431-11443. doi: 10.1021/acsami.2c18267. Epub 2023 Feb 27. ACS Appl Mater Interfaces. 2023. PMID: 36848495
-
Idarubicin-loaded biodegradable microspheres enhance sensitivity to anti-PD1 immunotherapy in transcatheter arterial chemoembolization of hepatocellular carcinoma.Acta Biomater. 2023 Feb;157:337-351. doi: 10.1016/j.actbio.2022.12.004. Epub 2022 Dec 10. Acta Biomater. 2023. PMID: 36509402
-
Multifunctional nanoplatforms application in the transcatheter chemoembolization against hepatocellular carcinoma.J Nanobiotechnology. 2023 Feb 27;21(1):68. doi: 10.1186/s12951-023-01820-7. J Nanobiotechnology. 2023. PMID: 36849981 Free PMC article. Review.
-
Management of hepatocellular carcinoma with transarterial chemoembolization in the era of systemic targeted therapy.Crit Rev Oncol Hematol. 2012 Aug;83(2):216-24. doi: 10.1016/j.critrevonc.2011.10.008. Epub 2011 Dec 3. Crit Rev Oncol Hematol. 2012. PMID: 22142656 Review.
Cited by
-
Microfluidic fabrication of X-ray-visible sodium hyaluronate microspheres for embolization.RSC Adv. 2023 Jul 10;13(30):20512-20519. doi: 10.1039/d3ra02812g. eCollection 2023 Jul 7. RSC Adv. 2023. PMID: 37435366 Free PMC article.
-
Temperature sensitive nanogel-stabilized pickering emulsion of fluoroalkane for ultrasound guiding vascular embolization therapy.J Nanobiotechnology. 2023 Nov 9;21(1):413. doi: 10.1186/s12951-023-02181-x. J Nanobiotechnology. 2023. PMID: 37946199 Free PMC article.
-
Synergistic Effects of Nanoscale CaO2 Combined with PD-1 Inhibitors in the Treatment of Hepatocellular Carcinoma: A Promising Combination.Int J Nanomedicine. 2024 Jan 5;19:137-154. doi: 10.2147/IJN.S440387. eCollection 2024. Int J Nanomedicine. 2024. PMID: 38196507 Free PMC article.
-
Real-world status, efficacy and prognosis analysis of first-line treatment for unresectable hepatocellular carcinoma in patients treated at multiple centres.Ann Med. 2024 Dec;56(1):2393291. doi: 10.1080/07853890.2024.2393291. Epub 2024 Aug 21. Ann Med. 2024. PMID: 39166271 Free PMC article.
-
Advances in experimental animal models of hepatocellular carcinoma.Cancer Med. 2023 Jul;12(14):15261-15276. doi: 10.1002/cam4.6163. Epub 2023 May 29. Cancer Med. 2023. PMID: 37248746 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous